Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|January 23, 2014
α-1-antitrypsin inhibits acute liver failure in miceNils Jedicke, Nina Struever, Nupur Aggrawal, et al.
Nature|February 19, 2016
Super-catastrophic disruption of asteroids at small perihelion distancesMikael Granvik, Alessandro Morbidelli, Robert Jedicke, et al.
Frontiers in Bioengineering and Biotechnology|February 24, 2022
High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver CancerIevgen V Pylypchuk, Huizhen Suo, Chanakarn Chucheepchuenkamol, et al.
HIV Medicine|November 2, 2021
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapyNils Jedicke, Metodi V Stankov, Anne Cossmann, et al.
Frontiers in Pharmacology|September 29, 2022
Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma <i>in vitro</i>Huizhen Suo, Inga Hochnadel, Nataliia Petriv, et al.
Elife|May 18, 2021
Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCsSrinu Tumpara, Matthias Ballmaier, Sabine Wrenger, et al.
JHEP Reports : Innovation in Hepatology|November 29, 2024
Essential roles of B cell subsets in the progression of MASLD and HCCNataliia Petriv, Huizhen Suo, Inga Hochnadel, et al.
Lung|March 18, 2024
Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of InflammationKokilavani Sivaraman, Bin Liu, Beatriz Martinez-Delgado, et al.
Toxicology and Applied Pharmacology|May 21, 2025
Dual therapy for amanita phalloides-induced acute liver failure in mice: A combination of etanercept and alpha-1 antitrypsinNils Jedicke, Nataliia Petriv, Huizhen Suo, et al.
Frontiers in Immunology|May 12, 2025
<i>In vivo</i> RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancerInga Hochnadel, Lisa Hoenicke, Nataliia Petriv, et al.
Pageof 3